These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763 [TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
5. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. Chan TY; Poon P; Pang J; Swaminathan R; Chan CH; Nisar M; Williams CS; Davies PD J Trop Med Hyg; 1994 Feb; 97(1):26-30. PubMed ID: 8107170 [TBL] [Abstract][Full Text] [Related]
6. [Phosphocalcium metabolism disorders in patients with active pulmonary tuberculosis]. Olmos JM; Martínez J; Riancho JA; Sánchez I; Amado JA; González Macías J Med Clin (Barc); 1991 Jan; 96(3):92-4. PubMed ID: 2033981 [TBL] [Abstract][Full Text] [Related]
7. The effects of muscle-building exercise on vitamin D and mineral metabolism. Bell NH; Godsen RN; Henry DP; Shary J; Epstein S J Bone Miner Res; 1988 Aug; 3(4):369-73. PubMed ID: 3265576 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of vitamin D metabolites in patients with hyperinsulinaemia. Ishida H; Seino Y; Tsuda K; Matsukura S; Miyamoto Y; Ishizuka S; Imura H Hum Nutr Clin Nutr; 1984 Nov; 38(6):473-5. PubMed ID: 6549179 [TBL] [Abstract][Full Text] [Related]
9. Regulation of parathyroid hormone and vitamin D in essential hypertension. Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis. Chesney RW; Hamstra A; Rose P; DeLuca HF Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110 [TBL] [Abstract][Full Text] [Related]
11. Parathormone, calcitonin, and vitamin D metabolites during normal fracture healing in geriatric patients. Meller Y; Kestenbaum RS; Shany S; Galinsky D; Zuili I; Yankovitch N; Giat J; Conforti A; Torok G Clin Orthop Relat Res; 1985 Oct; (199):272-9. PubMed ID: 4042489 [TBL] [Abstract][Full Text] [Related]
12. [Dysregulation of plasma 1,25(OH)2D in calcium restriction in hypercalciuric children]. Belon C; Dumas R; Tau C; Sabatier R; Bourdeau A; Garabedian M Arch Fr Pediatr; 1992; 49(6):519-24. PubMed ID: 1449353 [TBL] [Abstract][Full Text] [Related]
13. Calcium metabolism and its regulating hormones in patients with leprosy. Mautalen CA; Vaquero NL; Zeni SN; Mendez MA; Gonzalez DC; Bagur AC; Casco CA; Ladizesky MG Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):580-5. PubMed ID: 7868957 [TBL] [Abstract][Full Text] [Related]
14. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP. Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072 [TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease. Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657 [TBL] [Abstract][Full Text] [Related]
16. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460 [TBL] [Abstract][Full Text] [Related]
17. Evidence for alteration of the vitamin D-endocrine system in obese subjects. Bell NH; Epstein S; Greene A; Shary J; Oexmann MJ; Shaw S J Clin Invest; 1985 Jul; 76(1):370-3. PubMed ID: 2991340 [TBL] [Abstract][Full Text] [Related]